Literature DB >> 14632665

Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice.

Sukumar Pal1, Ellena M Peterson, Luis M de la Maza.   

Abstract

To establish the feasibility of inducing a protective immune response against a chlamydial genital infection in animals with different genetic backgrounds, groups of C3H/HeN (H-2k), BALB/c (H-2d) and C57BL/6 (H-2b) mice, were immunized intranasally with elementary bodies (EB) of the Chlamydia trachomatis mouse pneumonitis biovar. Following the intranasal immunization strong Chlamydia-specific humoral and cell-mediated immune (CMI) responses were detected in the three strains of mice. Eight weeks following immunization the animals were challenged with C. trachomatis in the genital tract. Vaginal cultures showed that the three strains of mice immunized with EB were significantly protected in comparison to the sham immunized animals. To determine the ability of this immunization protocol to protect against infertility six weeks after the genital challenge the animals were mated. Mice of the three strains immunized with EB showed significant protection as demonstrated by the number of animals that were fertile, and the number of embryos present in their uterine horns, in comparison to the sham immunized mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632665      PMCID: PMC1783049          DOI: 10.1046/j.1365-2567.2003.01748.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

Review 1.  Chlamydial genomics and vaccine antigen discovery.

Authors:  R S Stephens
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

2.  Interactions between the gonadal steroids and the immune system.

Authors:  C J Grossman
Journal:  Science       Date:  1985-01-18       Impact factor: 47.728

3.  Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.

Authors:  S Pal; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells.

Authors:  S G Morrison; R P Morrison
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection.

Authors:  X Yang; K T HayGlass; R C Brunham
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

6.  Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility.

Authors:  L M de la Maza; S Pal; A Khamesipour; E M Peterson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis.

Authors:  A L Barron; H J White; R G Rank; B L Soloff; E B Moses
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

8.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

9.  Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue.

Authors:  A J Stagg; M Tuffrey; C Woods; E Wunderink; S C Knight
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more
  7 in total

Review 1.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Leena Erkkilä; Taina Korhonen; Terttu Tiirola; Aini Bloigu; Pekka Saikku; Maija Leinonen
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.

Authors:  Sukumar Pal; Olga V Tatarenkova; Luis M de la Maza
Journal:  Immunology       Date:  2015-10-01       Impact factor: 7.397

Review 4.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

5.  Role of STAT1 in Chlamydia-Induced Type-1 Interferon Production in Oviduct Epithelial Cells.

Authors:  Kristen Lynette Hosey; Sishun Hu; Wilbert Alfred Derbigny
Journal:  J Interferon Cytokine Res       Date:  2015-08-11       Impact factor: 2.607

6.  Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays.

Authors:  Douglas M Molina; Sukumar Pal; Mathew A Kayala; Andy Teng; Paul J Kim; Pierre Baldi; Philip L Felgner; Xiaowu Liang; Luis M de la Maza
Journal:  Vaccine       Date:  2009-12-29       Impact factor: 3.641

7.  Protection of outbred mice against a vaginal challenge by a Chlamydia trachomatis serovar E recombinant major outer membrane protein vaccine is dependent on phosphate substitution in the adjuvant.

Authors:  Sukumar Pal; Salvador Fernando Ausar; Delia F Tifrea; Chunmei Cheng; Scott Gallichan; Violette Sanchez; Luis M de la Maza; Lucian Visan
Journal:  Hum Vaccin Immunother       Date:  2020-03-02       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.